Evidence map›Paper›PMID 36585574›Full record

ArticleJournal of cancer survivorship : research and practice2024

Patient-reported needs for coping with worry or fear about cancer recurrence and the extent to which they are being met: a survey study.

Yvonne L Luigjes-Huizer, Marije L van der Lee, Carol Richel, Roel A Masselink, Niek J de Wit, Charles W Helsper

Registry-linked trialAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05975437 (Effectiveness of persoNalized Care After Treatment for Nonmetastasized Breast Cancer Based On Risk of Recurrence, Personal Needs and Risk on), which is not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05975437 enrolling by invitationnot on this map

Effectiveness of persoNalized Care After Treatment for Nonmetastasized Breast Cancer Based On Risk of Recurrence, Personal Needs and Risk on (Late) Health Effects: the NABOR Study

Typeobservational_patient_registrySponsorComprehensive Cancer Centre The NetherlandsRan2023 to 2027Enrolled1,040ConditionsBreast Cancer, Breast Cancer Female, SurvivorshipArmspersonalized surveillance plans (PSP) and personalized aftercare plans (PAP)
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. How prevalent is fear of cancer recurrence beyond 5 years: a systematic review of validated assessments across tumour types.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Designing for delivery: a Delphi study of feasibility-informed implementation strategies for a fear of cancer recurrence clinical pathway.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Addressing the Needs of Breast Cancer Survivors.Current oncology reports · 2025
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yvonne L Luigjes-HuizerHelen Dowling Institute, Professor Bronkhorstlaan 20, 3723 MB, Bilthoven, The Netherlands. y.l.huizer@umcutrecht.nl.ORCID 0000-0003-1611-3627
Marije L van der LeeHelen Dowling Institute, Professor Bronkhorstlaan 20, 3723 MB, Bilthoven, The Netherlands.
Carol RichelDutch Federation of Cancer Patient Organisations, Utrecht, The Netherlands.
Roel A MasselinkDutch Federation of Cancer Patient Organisations, Utrecht, The Netherlands.
Niek J de WitJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.
Charles W HelsperJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMany cancer patients and survivors experience fear or worry about cancer recurrence (FCR). Evidence suggests support for FCR is their largest unmet need. We aimed to assess which types of support are needed, which providers are preferred and to what extent patients' needs are being met.

methodsTogether with the Dutch Federation of Cancer Patient Organisations (NFK), a purpose-designed questionnaire was distributed online via e-mail, newsletters and social media. All questions were multiple choice or Likert scales, except for an open-ended question about the preferred provider of care.

resultsOut of 5323 respondents, 4511 had experienced FCR and were included. Among them, 94% indicated a need for support. The required types of support that were reported the most were talking about FCR (69%), enjoyable activities for distraction (56%) and psychological help or coaching (40%). On average, younger respondents and women wanted more support than older respondents and men. Eighty-five percent of respondents received at least one type of support they wanted. Practical tips about FCR and additional medical check-ups were most often missed. Social contacts provided an important part of support, especially with talking and distracting activities. For other types of support, respondents usually preferred professionals.

conclusionsAlmost all patients who experience FCR have a need for support. Even though most receive some support, several gaps remain. IMPLICATIONS FOR CANCER SURVIVORS: Many report an unmet need for psychological help or practical tips about FCR. We recommend for healthcare providers to discuss FCR with patients and inform them about the support available.

Indexed as

Adaptation, PsychologicalAnxietyCancer SurvivorsFearNeoplasm Recurrence, LocalNeoplasmsAdultAgedFemaleHumansMaleMiddle AgedSocial SupportSurveys and QuestionnairesYoung AdultCancer survivorshipFear of cancer recurrenceNeedsOncology

Identifiers

PMID36585574
PMCPMC9803402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.